It is an Observational Study That Compare Prognosis of Typical and Atypical Systemic Lupus Erythematosus Presentation
NCT07350772 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 400
Last updated 2026-01-20
Summary
Atypical presentations of SLE including unusual initial symptoms, predominant organ involvement, late-onset disease and ANA-negative remain poorly characterized. These forms are often associated with delayed diagnosis and potentially worse clinical outcomes. Most existing studies focus on isolated rare manifestations rather than analyzing atypical SLE as a cohesive category. Understanding these differences is crucial and this study aims to compare atypical and typical SLE presentations to clarify variations in prognosis, treatment requirements and subsequent organ involvement.
Conditions
- Systemic Lupus Erythematosus (SLE)
Sponsors & Collaborators
-
Sohag University
lead OTHER
Eligibility
- Min Age
- 19 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2026-02-20
- Primary Completion
- 2027-02-28
- Completion
- 2027-08-31
Countries
- Egypt
Study Locations
More Related Trials
-
AntiDFS70 Lupus Nephritis
NCT06119763 ·Status: RECRUITING
-
Scrutinizing the Heterogeneity of SLE: Defining Phenotypes
NCT03348774 ·Status: UNKNOWN
-
The 2019 EULAR/ACR Classification Criteria as Predictor of Organ Damage in Systemic Lupus Erythematosus Patients
NCT06313151 ·Status: RECRUITING
-
Subgrouping SLE - a New Approach to Understand the Pathogenesis and Improve Treatment
NCT07102030 ·Status: RECRUITING
-
Gynecological Symptoms and Health-related Quality of Life in Egyptian Women With SLE
NCT05230316 ·Status: UNKNOWN
-
Evaluation of Serum Galectin-9 Level in Systemic Lupus Erythematosus Patients and it's Association With Disease Activity and Organ Damage
NCT04558814 ·Status: UNKNOWN ·Phase: NA
-
the Association Between Metabolic Syndrome and Its Components With Lupus Nephritis in Systemic Lupus Erythematosus Patients
NCT05964751 ·Status: UNKNOWN
-
Hematological Manifestations in Systemic Lupus Erythematosus Patients
NCT06936007 ·Status: COMPLETED
-
A Prospective Study of Cyclophosphamide in Systemic Lupus Erythematosus Treatment
NCT01689350 ·Status: COMPLETED ·Phase: NA
-
European LUpuS Inception-Cohort Developing initiATivE
NCT07209540 ·Status: NOT_YET_RECRUITING
-
A Study of Clinical Characteristics ,Risk Factors and Outcome of Lupus Nephritis Among Children With Systemic Lupus Erthromatousus in Sohag Univeristy Hospital
NCT06491602 ·Status: RECRUITING
-
A Study in Participants With Active Systemic Lupus Erythematosus With Inadequate Response to Glucocorticoids and ≥2 Immunosuppressants
NCT07175285 ·Status: RECRUITING
-
Associating Gastric Infection With Autoimmune Flare Severity in an Egyptians
NCT07157202 ·Status: NOT_YET_RECRUITING
-
Autophagy in Systemic Lupus Erythematosus
NCT03583853 ·Status: UNKNOWN
-
AGR+PNI as Predictors of Systemic Lupus Erythematosus Disease Activity
NCT07043153 ·Status: RECRUITING
-
Assessment of Anxiety, Depression, Sleep Quality and Quality of Life in Systemic Lupus Erythematosus Patients
NCT05971498 ·Status: UNKNOWN
-
Weaning of Immunosuppression in Nephritis of Lupus
NCT01284725 ·Status: COMPLETED ·Phase: PHASE3
-
Prognostic Factors for Treatment Responses in Patients With Active Lupus Nephritis at Sohag University Hospital
NCT04756492 ·Status: UNKNOWN
-
Prognostic Factors for Fatigue in Patients With Systemic Lupus Erythematosus
NCT07123220 ·Status: COMPLETED
-
Systemic Lupus and Adverse Pregnancy Outcome
NCT03171103 ·Status: UNKNOWN
-
Autotaxin as Abiomarker in Systemic Lupus Erythematosus Patients
NCT06063668 ·Status: NOT_YET_RECRUITING
-
Prediction of Outcome of Lupus Nephritis
NCT02403115 ·Status: UNKNOWN
-
Value of Uric Acid as Early Predictor of Lupus Nephritis
NCT05402735 ·Status: UNKNOWN
-
Autologous Stem Cell Transplantation for Refractory Systemic Lupus Erythematosus (ASSIST)
NCT00750971 ·Status: UNKNOWN ·Phase: PHASE2
-
Prospective Study of Rapamycin for the Treatment of SLE
NCT00779194 ·Status: COMPLETED ·Phase: PHASE2